About
CoaguSense Inc, founded in 2008 and based in Fremont, California, is a medical device company that specializes in managing coagulation disorders. The company develops and sells innovative in-vitro diagnostic products, particularly the Coag-Sense PT/INR Monitoring System. This device is recognized for its precision in measuring prothrombin time (PT) and international normalized ratio (INR), which are essential for patients undergoing anticoagulant therapy. The Coag-Sense system utilizes proprietary micromechanical clot-detection technology, allowing for accurate results with a small blood sample. It features modern connectivity options such as Wi-Fi, Bluetooth®, and Near Field Communication (NFC), along with a user-friendly color touchscreen. This makes it suitable for use in various settings, including anticoagulation clinics and home environments. CoaguSense is committed to customer support, with a dedicated team providing assistance and guidance to both healthcare professionals and patient self-testers. The company operates with fewer than 100 employees and is a subsidiary of i-SENS, Inc., which acquired it in 2016.
Technologies
Keywords
Company Information
-
Employees 26
-
Founded 2008
-
Annual Revenue $23436000
-
Total Funding $4999999
Location
48378 Fremont Blvd, Fremont, California, United States, 94538-6511